Webinar: Life Sciences Investor Survey IV

Investor Expectations for the Life Sciences Sector

life science

A panel of healthcare and finance experts will discusses the results from FTI Consulting’s fourth annual Life Sciences Investor Survey, and explore the market dynamics currently driving investment decisions and transactions in the industry.

Date: Thursday, March 13, 2014
Length: 60 minutes

Learn About

  • Investors’ outlook for healthcare and life sciences stock performance
  • Key drivers of investment decisions, and valuations for public and private companies
  • Expectations for industry IPOs and M&A activity in 2014
  • Regulations impacting the sector and transaction environment
  • Key trends in shareholder engagement and communication strategies for enhancing enterprise value

Who Should Watch?

  • Business Development Professionals
  • Buy-Side Investors
  • Chief Communications Officers (CCOs)
  • C-Suite Executives
  • Investment Bankers
  • Investor Relations Officers (IROs)
  • Lawyers
  • Sell-Side Analysts
  • Venture Capitalists


  • Judy Brown, Executive Vice President and Chief Financial Officer, Perrigo Company
  • Alan Hartman, Partner, Centerview Partners
  • Tom Crawford, Senior Managing Director, FTI Consulting — Strategic Communications
  • Barbara Ryan, Managing Director, FTI Consulting — Strategic Communications

About the Research

FTI Consulting — Strategic Communications’ fourth annual Life Sciences Investor Survey assesses European and U.S. investors’ insights and expectations around a number of key industry-related topics. The study’s findings underscore investors’ overall optimism toward the outlook for healthcare stock performance and the anticipated continued strength of the transaction environment in the sector. The research also reveals a number of key trends in shareholder engagement for healthcare and life sciences companies to consider.

More Info

Share this page